John Nicholson, SVP & Chief Operating Officer at NEKTAR THERAPEUTICS (NKTR), sold 203,400 shares at $19.24 ($3.9M) on 2017-06-07, disclosed to the SEC on 2017-06-09.
Open-market sale of $3.9M NKTR by SVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.24 | 101,700 | $2.0M | 50.0% |
| 2 | $19.24 | 101,700 | $2.0M | 50.0% |
| Total | $19.24 avg | 203,400 | $3.9M | 100% |
| Filing → |
| NKTR | SELL | 2019-02-21 | $324K | — | Filing → |
| NKTR | SELL | 2019-01-30 | $2.7M | — | Filing → |
| NKTR | SELL | 2018-11-19 | $458K | — | Filing → |